• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Cardiovasc Dis . Myocarditis presentation following COVID-19 virus infection versus COVID-19 vaccination

tetano

Editor, Senior Moderator
Am J Cardiovasc Dis


. 2022 Oct 15;12(5):272-277.
eCollection 2022.
Myocarditis presentation following COVID-19 virus infection versus COVID-19 vaccination


Usha Yendrapalli[SUP] 1 [/SUP], Ali Hassoun[SUP] 2 [/SUP], Roderick M Zalamea[SUP] 3 [/SUP], Abdulwahab Hritani[SUP] 4 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) vaccine-induced cardiac injury has recently emerged as a major public health concern around the globe. There are reported cases of COVID-19 vaccine-induced myocarditis, but they are generally extremely rare and mild. In contrast, COVID-19 infection can cause acute cardiac injury with poor prognosis and high mortality rates. Herein, we describe the difference in patients' presentation by comparing two cases of myocarditis. One after contracting COVID-19 virus infection with a severe clinical course, and the other patient developed myocarditis post-COVID-19 vaccine.

Keywords: COVID; myocarditis; vaccine.
 
Back
Top Bottom